TB-500 (0.5mg/capsule), 60 Capsules
$254.95
TB-500 (Thymosin Beta-4) capsules provide an oral administration format for the 43-amino-acid actin-binding peptide, enabling oral route investigations alongside the lyophilized vial format. As with the injectable format, the active compound interacts with G-actin through its LKKTET motif, influencing actin… CAS: 77591-33-4 | Formula: C212H350N56O78S | Content: 30 mg (0.5 mg per capsule) | Research use only | Third-party lab tested.
Buy TB-500 (0.5mg/capsule), 60 Capsules – Swiss Chems USA
TB-500 (0.5mg/capsule), 60 Capsules — Research Overview
TB-500 (Thymosin Beta-4) capsules provide an oral administration format for the 43-amino-acid actin-binding peptide, enabling oral route investigations alongside the lyophilized vial format. As with the injectable format, the active compound interacts with G-actin through its LKKTET motif, influencing actin polymerization dynamics, cytoskeletal organization, and cell migration–associated signaling pathways. Experimental investigations have examined TB-500 in relation to actin-regulatory mechanisms, molecular signaling networks, and pathway-specific processes involved in cytoskeletal biology. Research applications include oral versus parenteral comparative studies, actin cytoskeletal pathway investigation, cell migration signaling research, and mechanistic evaluation of actin-associated regulatory systems.
- High Purity – 99% Purity Guaranteed
- Independently Lab Tested
- Research Grade Quality
- For Laboratory Research Use Only
Intended use: This material is supplied for laboratory and in-vitro research only. It is not a drug, food, or cosmetic and is not intended for human or animal consumption.
TB-500 (0.5mg/capsule), 60 Capsules Chemical Properties
| Property | Specification |
|---|---|
| Chemical Formula | C212H350N56O78S |
| Synonyms | Thymosin Beta-4, Tβ4, TB500 capsules |
| Molar Mass | 889.01 g/mol |
| CAS Number | 77591-33-4 |
| PubChem CID | 16132341 |
| Total Compound Content | 30 mg (0.5 mg per capsule) |
| Shelf Life | 36 months |
TB-500 (0.5mg/capsule), 60 Capsules Research Applications
TB-500 (Thymosin Beta-4 analogue) capsules (0.5 mg/capsule) provide an oral administration format for the 43-amino-acid actin-binding peptide. The primary characterized mechanism—LKKTET motif-mediated interaction with G-actin—is identical to the injectable vial format. The capsule format enables investigation of alternative administration routes and provides a useful platform for studies examining compound transport, peptide stability, and route-dependent signaling characteristics. Experimental research has examined TB-500 in relation to actin polymerization dynamics, cytoskeletal organization, cell migration-associated pathways, and molecular signaling networks linked to actin-regulatory systems. The oral format is also useful for studies requiring non-parenteral delivery approaches or investigations of peptide-associated signaling processes across distinct experimental environments. Independently third-party HPLC-tested; COA available per batch.
TB-500 (0.5mg/capsule), 60 Capsules Frequently Asked Questions
What is the research basis for the TB-500 capsule format?
TB-500 capsules provide an alternative formulation format for investigating the same 43-amino-acid actin-binding peptide found in vial preparations. Experimental studies have examined formulation-dependent characteristics, peptide stability properties, compound-processing mechanisms, and actin-associated signaling pathways. The capsule format is useful for comparative investigations examining how different formulations influence experimental parameters while retaining the same underlying molecular structure.
What is the difference between TB-500 capsules and TB-500 vials for laboratory research?
TB-500 capsules and TB-500 vials contain the same active compound and share the same core actin-associated mechanism. The primary distinction is the formulation format, allowing researchers to investigate different preparation strategies, formulation characteristics, and experimental design variables. The compound itself remains unchanged, while the format provides flexibility for a range of laboratory research applications.
Does the capsule format of TB-500 change its mechanism of action compared to vial preparations?
No. The core mechanism involving G-actin interaction through the LKKTET motif is intrinsic to the TB-500 molecule and remains unchanged regardless of formulation format. Experimental differences between formats relate to formulation characteristics rather than the underlying molecular mechanism. This makes the capsule format useful for comparative investigations of actin-regulatory pathways, peptide-associated signaling processes, and formulation-dependent experimental variables.
Research Use Disclaimer
All product information is provided for educational and laboratory research reference only. Any form of introduction into humans or animals is prohibited. Handle only in licensed research settings in accordance with applicable laws and institutional protocols.
Related products
BPC-157 with Arginine Salt
Price range: $39.99 through $599.50
Clomiphene, 1500mg (25mg/capsule)
Original price was: $79.95.$69.95Current price is: $69.95.
Reviews
There are no reviews yet.